Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast CancerShanu Modi, David Cameron, William Jacot et al.|New England Journal of Medicine|2022Cited by 2.5k
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancerDavid Miles, Giulia Bianchi, Monika Patre et al.|Annals of Oncology|2021Cited by 724
Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a weekYawei Hu, Peng Liu, Xizhao Sui et al.|Nature Communications|2021Cited by 261
MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1Lijuan Sun, Jiayin Li, Yandan Yao et al.|Oncogene|2011Cited by 248
Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancerShicheng Su, Erwei Song, Jiang Liu et al.|Cell Research|2017Cited by 225